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Myristica fatua Houtt. is one of the endemic plants growth 
in Wallace region. Isolation of the secondary metabolite 
compounds from the ethyl acetate fraction of the bark of 
Myristica fatua Houtt. has been done using some 
chromatography techniques afforded two resorcinol compounds, 
malabaricone C (1),  and malabaricone B (2). The structures of 
1-2 were determined using spectroscopic techniques, including 
mass spectrometry, 1D-NMR and 2D-NMR. Both compounds 
showed in vitro cytotoxic activity against the breast carcinoma 
cancer cell lines MCF-7 using alamar blue assay method, with 
IC50 of 2.38 and 0.71 μg/mL, respectively.  
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INTRODUCTION  
Myristica (Myristicaceae) widely 
distributed from India and South East Asia to 
North Australia and the Pacific Islands.Myristica 
comprising of 72 species, and one of them is 
Myristica fatua Houtt (Zachariah, 2008). M. fatua 
is endemic to the Kalimantan, Sulawesi, 
Moluccas in Indonesia, beside the other region 
such as India, Philippines, New Guinea, 
Solomon Island, Pacific Islands, and New 
Caledonia. Mekongga forest is a conservation 
forest in Kolaka District, Northeast Sulawesi, 
Indonesia, which have so many uniques and 
endemic bioresources (Lim, 2012).  
Lignans and acylphenols are the 
secondary metabolites major compound 
produced by this family (Nemethy, 1986; Woo, 
1987; Cooray, 1987; Kumar, 1988; Hada, 1988; 
Nakatani, 1988; Herath, 1996; Herath, 1997; 
Pham, 2000& 2002; Talukdar, 2000; Calliste, 
2010; Cuong, 2011; Chong, 2011; Manjunatha, 
2011; Ragasa, 2013; Cao, 2013; Cao, 2015; 
Acuna, 2016; Wahab, 2016; Pandey, 2016; 
Sivasothy, 2016). In addition to their activities 
of antioxidant, antibacterial, antimicrobial, 
nematocide, and cytotoxic (Pham, 2000; 
Talukdar, 2000; Pham, 2002), antiinflammatory 
(Cuong, 2011; Cao, 2013; Cao, 2015), 
anxiogenic (Sonavane, 2002),antihelmintic 
(Lopez, 2015), cholinesterase inhibitor (Wahab, 
2016), terapeutic (Jangid, 2014), acylphenols 
also been known to have alpha-glucosidase 
inhibitor activity (Sivasothy, 2016).  
There is no reported study on M. fatua, 
except a study for antioxidant and antibacterial 
activities (Viveka, 2016) and its potency as α-
glucosidase inhibitor (Sivasothy, 2016). It is 
encourages us to do a phytochemical study 
about secondary metabolite compounds 
contained in Myristica fatua Houtt. In this paper 
we will describe the isolation of the acylphenols 
from M. fatua, the structure of malabaricone B 
(1) and C (2), and their cytotoxic activity against 
breast carcinoma MCF-7 cell lines. 
 
MATERIALS AND METHODS 
General.  
The 1D- and 2D-NMR spectra were 
recorded by JEOL JNM-ECA 500 spectrometer 
with CD3OD as a solvent and TMS as an 
internal standard.  LC-ESI-MS were measured 
by the Mariner Biospectrometry-Finnigan 
instrument with methanol p.a (Merck) as a 
solvent. Column chromatography was 
performed using silica gel (200-300 mesh, 
Kieselgel 60, E. Merck) as stationary phase.  
 
Plant material.  
The bark of Myristica fatua were collected 
from the Mekongga Forest, District of Kolaka, 
Southeast Sulawesi, Indonesia. The plant was 
determined and deposite as a specimen in 
Herbarium Bogoriense, Research Centre for 
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Biology, Indonesian Institute of Sciences, 
Cibinong-Bogor, Indonesia.   
 
Extraction and isolation 
Dried and powdered bark of M. fatua 
1.5k g were macerated in methanol, evaporated 
using rotary evaporator to get 41.9g                
methanol crude extract. Methanol soluble 
fraction ( 20g) was column chromatographed 
over silica gel and eluted with a gradient solvent 
system of n-hexane:EtOAc to obtain 10 
fractions (F1- F10). Fraction 5(F5) further 
sephadex chromatographed using methanol: 
dichloromethane (1:1) as system solvent to give 
7 sub-fraction (SF1-SF7). Compound 1 (20mg) 
and 2 (30mg) was crystallized from sub-fraction 
5.4 (SF-5.4) and sub-fraction 5.5 (SF-5.5), 
respectively.  Chemical structure identification 
of compound 1 and 2 performed with liquid 
chromatography-mass spectroscopy (LC-MS) 
and 1D- and 2D-nuclear magnetic resonance 
(NMR). 
Compound 1: Malabaricone C, ESI-MS 
m/z 359 [M+H]; NMR (JEOL JNM-ECA 500) 
δH (500 MHz, in CD3OD): 6.33 (2H, d, J 8.43 
Hz, H-18/20), 7.19 (1H, t, J 8.43 & 7.79 Hz, H-
19), 6.46 (1H, dd, J 2.60 & 1.95 Hz, H-15), 6.59 
(1H, d, J 1.95, H-11), 6.64 (1H, d, J 7.79 Hz, H-
14), 3.11 (2H, t, H-2), 1.66 (2H, p, H-3), 1.33 
(8H, br.s, H-4/5/6/7), 1.55 (2H, m, H-8), 2.44 
(2H, t, H-9). δC (125 MHz, in CD3OD): 45.7 
(C-2), 25.6 (C-3), 30.4 (C-4), 30.6 (2C, C-5/7), 
30.7 (C-6), 33.1 (C-8), 36.4 (C-9), 135.8 (C-10), 
116.6 (C-11), 146.1 (C-12), 144.1 (C-13), 116.3 
(C-14), 120.7 (C-15), 111.5 (C-16), 163.5 (2C, 
C-17/21), 108.4 (2C, C-18/20), 136.9 (C-19), 
209.5 (C-1, C=O). 
Compound 2: Malabaricone B, ESI-MS 
m/z 342 [M+H]; NMR (JEOL JNM-ECA 500) 
δH (500 MHz, in CD3OD): 6.33 (2H, d, J 8.43 
Hz, H-18/20), 7.19 (1H, t, J 8.43 & 8.45 Hz, H-
19), 6.96 (2H, d, J 8.43 Hz, H-11/15), 6.67 (2H, 
d, J 8.43 Hz, H-12/14), 3.11 (2H, t, H-2), 1.66 
(2H, p, H-3), 1.33 (8H, br.s, H-4/5/6/7), 1.55 
(2H, p, H-8), 2.44 (2H, t, H-9). δC (125 MHz, in 
CD3OD): 45.7 (C-2), 25.6 (C-3), 30.4 (C-4), 
30.6 (2C, C-5/7), 30.7 (C-6), 33.1 (C-8), 36.4 
(C-9), 135.8 (C-10), 130.2 (2C-11/15), 116.0 
(2C, C12/14), 156.3 (C-13), 111.5 (C-16), 163.5 
(2C, C-17/21), 108.3 (2C, C-18/20), 136.8 (C-
19), 209.8 (C-1, C=O) 
 
Cancer cells line preparations 
In this study, we used breast carcinoma 
(MCF-7) cells line as cancer cells. Cancer cell 
was cultured at 37ºC of temperature with 95% 
moisture content and 5% CO2 in DME 
medium contained 10% of FBS for 3 days 
(until the cell cultures undergo confluent 60-
70%). Removed and replace the medium with a 
new medium and continued the incubation for 
next 24h. Wash Cultured cells with PBS 1-2 




Cytotoxic assay carried out using Alamar 
Blue method(Alamar Blue Assay, U.S. Patent 
No.5,501,959). 100µL of cells line was 
supplemented with 10L of samples, incubated 
at temperature 37°C for 24h. The coloring 
process was done through the addition of 
Alamar blue solution for 4h. The color intensity 
of the cells line was measured by using ELISA 
plate reader at 560nm (excitation) and 590nm 
(emission). Percent viability is calculated using 
the formula as follows: 
 
OD (cell+sample)-OD (negative control) 
x 100 = % viability 
OD (cells) - OD (negative control) 
 
While IC50 of the active samples was 
calculated using linear regression analysis 
between percent of survival against the 
concentration of the sample 
 
RESULTS AND DISCUSSION 
Compound 1 was isolated as yellowish 
brown crystals, its has positive ESI-MS 
[M+H]+ at m/z 359. 1H-NMR data showed 
that compound 1 has 6 aromatic protons at δ 
6.46, 6.64, 6.59 in 1st aromatic ring, 6.33 (2H), 
7.19 in 2nd aromatic ring and 8pair of 
methylene proton groups at δ 3.11, 1.66, 1.33 
(4-CH2), 1.55, and 2.44. Three proton peaks at 
δ 6.46 (1H, dd, J 2.60 & 1.95 Hz), 6.59 (1H, d, J 
1.95 Hz), 6.64 (1H, d, J 7.79 Hz) in 1st ring 
showed the AMX pattern of aromatic ring 
proton system, its mean that in 1st aromatic 
ring has 2 type of aromatic proton position: 
ortho position between δ 6.46 and δ 6.64, and 
meta position between δ 6.46 and δ 6.59 
(Figure 1a). In addition, two proton peaks at δ 
6.33 (2H, d, J 8.43 Hz) and 7.19 (1H, t, J 8.43 & 
Resorcinol Compounds Isolated 
84   Volume 28 Issue 2 (2017) 
7.79Hz) in 2nd ring showed the AB2 pattern of 
aromatic ring proton system, indicated that 2nd 
aromatic ring has two symmetric proton peak 
at δ 6.33, which has correlation with proton 
peak at δ 7.19 in ortho position (Figure 1b). 
Two methylene proton peaks of compound 1 
showed downfield chemical shift at δ 3.11 and 
2.44 indicated that their position were located 
close to the electronegatif atom or attached to 
aromatic ring. HMBC data (Figure 2) showed 
that proton peak at δ 3.11 has a correlation 
with carbonyl group at δ 209.5,and another 
proton peak (δ 2.44) has three different 
correlations with three different carbon atom (δ 
135.8; 120.7; 116.6) from 2nd aromatic ring. 
13C-NMR data showed 18 peak of 
carbon atoms including a downfield carbonyl 
signal at δ 209.5. Three carbon peaks at δ 30.6, 
108.4, and 163.5 showed higher intensity 
compared to other carbon peaks, indicated that 
compound 1 has three symmetric carbon 
atoms. Five sp2 methine carbon peaks can be 
observed at 108.4 (2C), 116.3, 116.6, 120.7, and 
136.9, two quaternary sp2 carbon at δ 111.5 
and 135.8, and four oxyaryl carbons at δ 144.1, 
146.1, and 163.5(2C).  
The HMQC (1J(C-H)) and HMBC (2J(C-H) 
to 4J(C-H)) correlations of compound 1 (Figure 2). 
The HMQC correlation between a downfield 
proton atom at δ 3.11 with a downfield 
methylene carbon atom at δ 45.7 indicated that 




































































































Figure 2. HMQC and HMBC correlations of compound 1 
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Figure 5. HMQC and HMBC correlations of compound 2 
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atom, were supported by the HMBC 
correlation between proton atom at δ 3.11 with 
carbonyl group at δ 209.5, the same things 
happen to methylene group at δH 1.66/δC 25.6. 
Other HMBC correlations between a downfield 
proton atom at δ 2.44 with carbon quaternary 
sp2 (1st aromatic ring) at δ 135.8 showed the 
influence of the aromatic ring to the chemical 
shift value of the carbon atom at δ 36.4. The 
ESI-MS spectra (Figure 3) showed a molecular 
ion [M+H]+ 359.46 or [M+] 358.46, 
corresponds to molecular formula C21H26O5. 































Figure 6. ESI-MS spectra of compound 2 
 
 
Tabel I. 13C- and 1H-NMR date for malabaricone C (1) (1H:500 MHz, 13C: 125 MHz, in CD3OD; 
carbon numbering does not follow the official rule and is used here for simplicity) 
 
 1 Malabaricone C (Pham, 2000) 
δC δH (m, J (Hz)) δC δH (m, J (Hz)) 
1 209.5  208.7  
2 45.7 3.11 (t) 44.6 3.09 (t) 
3 25.6 1.66 (p) 24.3 1.62 (p) 
4 30.4 1.33 (br.s) 29.2 1.30 (m) 
5 30.6 29.2 1.26 (br.s) 
6 30.7 29.2 
7 30.6 28.9 
8 33.1 1.55 (m) 31.4 1.49 (p) 
9 36.4 2.44 (t) 35.0 2.39 (t) 
10 135.8  135.3  
11 116.6 6.59 (d, 1.95) 115.2 6.62 (d, 2.0) 
12 146.1  143.8  
13 144.1  141.8  
14 116.3 6.64 (d, 7.79) 114.9 6.67 (d, 8.0) 
15 120.7 6.46 (dd, 2.60 & 1.95) 120.0 6.50 (dd, 2.0 & 8.0) 
16 111.5  110.1  
17 163.5  161.8  
18 108.4 6.33 (d, 8.43) 107.5 6.31 (d, 8.1) 
19 136.9 7.19 (t, 8.43 & 7.79) 135.7 7.12 (t, 8.1) 
20 108.4 6.33 (d, 8.43) 107.5 6.31 (d, 8.1) 
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Based on the NMR data, supported by ESI-MS 
data and reference (Table I), compound 1 was 
identified as malabaricone C (Figure 2)(Pham, 
2000). 
Compound 2 was isolated as yellowish 
brown, its has positive ESI-MS [M+H]+at m/z 
343. 1H-NMR data showed that compound 2 
has 7 aromatic proton at δ 6.33 (2H), 7.19 in 1st 
aromatic ring, 6.96 (2H), 6.67 (2H) in 2nd 
aromatic ring and 8 pair of methylene proton 
groups at δ 3.10, 1.66, 1.33 (4-CH2), 1.55, and 
2.49. Two proton peaks at δ 6.67 (2H, d, J 8.43 
Hz) and 6.96 (2H, d, J 8.43 Hz) in 1st              
ring indicated the presence of AA’XX’ pattern 
Tabel II. 13C- and 1H-NMR data for malabariconesB (2) (1H:500 MHz, 13C: 125 MHz, in CD3OD; 
carbon numbering does not followthe official rule and is used here for simplicity) 
 
 2 Malabaricone B (Pham, 2000) 
δC δH (m, J (Hz)) δC δH (m, J (Hz)) 
1 209.8  208.6  
2 45.7 3.11 (t) 44.7 3.10 (t) 
3 25.6 1.66 (p) 24.4 1.64 (p) 
4 30.4 1.33 (br.s) 29.5 1.29 (br.s) 
5 30.6 29.0 
6 30.7 29.0 
7 30.6 29.2 
8 33.1 1.55 (m) 31.6 1.51 (p) 
9 36.4 2.44 (t) 35.0 2.46 (t) 
10 135.8  134.6  
11 130.2 6.96 (d, 8.43) 129.3 6.96 (m, 8.4) 
12 116.0 6.67 (d, 8.43) 115.0 6.69 (m, 8.4) 
13 156.3  153.6  
14 116.0 6.67 (d, 8.43) 115.0 6.69 (m, 8.4) 
15 130.2 6.96 (d, 8.43) 129.3 6.96 (m, 8.4) 
16 111.5  110.1  
17 163.5  161.6  
18 108.3 6.33 (d, 8.43) 107.8 6.32 (d, 8.2) 
19 136.8 7.19 (t, 8.43) 135.7 7.14 (t, 8.2) 
20 108.3 6.33 (d, 8.43) 107.8 6.32 (d, 8.2) 




Figure 7. Viability plots of compound 1 and compound 2 against breast carcinoma (MCF-7) cells 
line. 
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of aromatic ring proton system, its mean that        
in 1st aromatic ring has four symmetric proton 
peaks with one type of ortho aromatic           
proton  position  at δ 6.96 and 6.67 (Figure 4a). 
In addition, two proton peaks at δ 6.33 (2H, d, 
J 8.43 Hz) and 7.19 (1H, t, J 8.43 Hz) in 2nd 
ring showed the AB2 pattern of aromatic ring 
proton system(Figure 4b), indicated that 2nd 
aromatic ring has two simetris proton peak at δ 
6.33, which has correlation with proton peak at 
δ 7.19 in ortho position. Both AA’XX’ and AB2 
patterns were supported by HMQC and 
HMBC correlation data (Figure 5).13C-NMR 
data showed 16 peak of carbon atoms including 
a downfield carbonyl signal at δ 209.8. Five 
carbon peaks at δ 30.6, 108.4, 116.0, 130.3, and 
163.5 showed higher intensity compared to 
other carbon peaks, indicated that compound 2 
has five simetris carbon atoms. Seven sp2 
methine carbon peaks can be observed at 108.4 
(2C), 116.0 (2C), 130.3 (2C), and 136.9, two 
quaternary sp2 carbon at δ 111.5 and 135.0,  
and three oxyaryl carbons at δ 156.3, and 
163.5(2C).  
The HMQC (1J(C-H)) and HMBC (2J(C-H) 
to 4J(C-H)) correlations of compound 2 illustrated 
in Figure 5. The HMQC correlation between a 
downfield proton atom at δ 3.10 with a 
downfield methylene carbon atom at δ 45.8 
indicated that both atom were located near the 
electronegatif atom, were supported by the 
HMBC correlation between proton atom at δ 
3.10 with carbonyl group at δ 209.8, the same 
things happen to methylene group at δH 
1.66/δC 25.8. Other HMBC correlation 
between a downfield proton atom at δ 2.49 
with carbon quaternary sp2 (1st aromatic ring) 
at δ 135.0 showed the influence of the aromatic 
ring to the chemical shift value of the carbon 
atom at δ 36.1. The ESI-MS spectra (Figure 6) 
showed a molecular ion [M+H]+ 343.45 or 
[M+] 342.45 indicates the molecular weight of 
the compound corresponds to molecular 
formula C21H26O4.  
Based on the NMR data, supported by 
ESI-MS data and reference (Table II), 
compound 2 was identified as malabaricone B 
(Figure 5) (Pham, 2000). 
 
Cytotoxic assay 
Compound 1-2 were examined for their 
cytotoxicity against the breast carcinoma 
(MCF-7) cells line (Figure 7) and showed that 
both compounds were active as anticancer 
compounds against breast carcinoma (MCF-7) 




Isolation and purification of ethyl acetate 
fraction 5 (F-5) of the bark of M. fatua using 
column chromatography method, and structure 
elucidation based on spectroscopic data analysis 
result have been done. Can be concluded that 
compound 1 and 2 are malabaricone C and 
malabaricone B, respectively. Both compounds 
have high cytotoxicity activity against breast 
carcinoma (MCF-7) cells line with IC50 values 
are  2.68 and 0.71µg/mL, respectively. 
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